Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers

Completed

Phase 1 Results N/A

Summary of Purpose

The primary objective of this study is to evaluate the safety and tolerability of RP-1127 (glyburide for injection), administered as a bolus dose followed by a 3 day continuous infusion. The secondary objectives are to assess the pharmacokinetics of RP-1127 and blood glucose and serum insulin PD responses to RP-1127.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 June 2014.

1 Feb 2010 14 Apr 2010 1 May 2010 1 May 2010 1 May 2010 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts

Not available